Immunogenicity and safety of COVID-19 vaccine in lung cancer patients receiving anticancer treatment: A prospective multicenter cohort study

This study assessed the immunogenicity and safety of the BNT162b2 mRNA vaccine in lung cancer patients receiving anticancer treatment. We enrolled lung cancer patients receiving anticancer treatment and non-cancer patients; all participants were fully vaccinated with the BNT162b2 vaccine. Blood samp...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakashima, Kei, Ishida, Masayuki, Matsui, Hiroki, Yoshida, Chihiro, Nagai, Tatsuya, Shiraga, Minoru, Nakaoka, Hiroshi, Otsuka, Yoshihito, Nakagama, Yu, Kaku, Natsuko, Nitahara, Yuko, Kido, Yasutoshi, Hirota, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746471/
https://www.ncbi.nlm.nih.gov/pubmed/36369871
http://dx.doi.org/10.1080/21645515.2022.2140549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746471/
https://www.ncbi.nlm.nih.gov/pubmed/36369871
http://dx.doi.org/10.1080/21645515.2022.2140549

Ejemplares similares